KORU Medical Systems, Inc.

KRMD Healthcare Medical Instruments & Supplies

KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

3.00 0.03 −0.99%
Market cap
$139.9M
P/E
0.0×
Fwd P/E
−89.3×
Dividend yield
—
F-score
5/9
Altman Z
14.46
Beneish M
−2.90
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
4.29 4.63 6.52 4.53
P/FCF ratio
775.14 1,645.82 0.00 0.00
P/Operating CF
895.66 13,625.60 245.11 2,707.87
P/B ratio
10.72 11.84 15.74 10.76
Price to Tangible BV
11.81 12.36 16.40 11.22
EV/Sales
4.11 4.43 6.31 4.32
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
133.24 268.09 561.32 549.31
EV/FCF
742.24 1,574.16 (532.53) (992.05)
Quick Ratio
2.00 1.70 1.88 1.78
Current Ratio
2.72 2.33 2.44 2.48
Net Debt/EBITDA
(9.82) 13.07 23.90 12.59
Debt/Assets
0.26% 0.16% 0.28% 0.43%
Debt/Equity
0.00 0.00 0.00 0.01
Asset Turnover
1.69 1.55 1.48 1.43
Operating CF/Net income
0.86 (0.02) (2.25) (0.08)
Capex/Depreciation
(2.75) (0.46) (2.35) (0.26)
Research and Development Expense of Revenue
8.88% 11.19% 10.51% 8.97%
Selling, General and Administrative Expense of Revenue
49.31% 55.95% 55.44% 57.63%
Intangible Assets out of Total Assets
0.06 0.02 0.02 0.03
Share Based Compensation of Revenue
3.80% 5.79% 8.93% 6.03%
Graham Net Nets
0.05 0.04 0.03 0.05
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(1.06%) (1.26%) (1.11%) (2.21%)
Free Cash Flow Yield
0.13% 0.06% (0.18%) (0.10%)
Revenue per Share
0.26 0.25 0.24 0.23
Operating CF per Share
0.00 0.00 0.02 0.00
Capex per Share
(0.01) 0.00 (0.01) 0.00
Free Cash Flow per Share
(0.01) 0.00 0.01 0.00
Cash per Share
0.18 0.19 0.19 0.18
Shareholders Equity per Share
0.39 0.37 0.37 0.36
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.39 0.37 0.37 0.36
Free Cash Flow
(0.36) (0.08) 0.67 0.01
Working Capital
12.33 11.74 11.79 11.59
Capital Expenditures
(0.58) (0.09) (0.42) (0.05)
Net Current Asset Value
9.60 8.92 8.84 8.78
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.05 0.01 0.04 0.01
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
5.59 6.29 6.26 5.38
Average Payables
2.00 2.32 1.96 1.77
Average Inventory
4.23 3.88 3.24 4.17
Average Assets
26.74 27.90 27.71 27.25
Average Common Equity
17.29 16.63 16.93 17.10

Fold the line items

Columns are period end dates